SCHEMBL514919

SCHEMBL514919

CSc1ccccc1[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812717 0.81 ALDH1A1 (0.43)
Ammonia Solution, Strong SCHEMBL16781743 0.78 ALDH1A1 (0.41)
SCHEMBL2187016 0.75 PDE7A (0.35)
SCHEMBL5890646 0.73 KDM4E (0.52)
SCHEMBL28443362 0.73 POLB (0.41)
SCHEMBL11586245 0.73
SCHEMBL2986829 0.73 KMT2A (0.46)
SCHEMBL31087243 0.73 KDM4E (0.52)
SCHEMBL199800 0.73 ALDH1A1 (0.39)
SCHEMBL21830229 0.72 SMN1; SMN2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465869-B1 MODULATORS OF LXR EXELIXIS PATENT CO LLC (US) 2013-05-15 EP claimed
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US claimed
EP-1856060-A1 SUBSTITUTED 1,1,1-TRIFLUORO-3-[(BENZYL)-(PYRIMIDIN-2-YL)-AMINO]-PROP AN-2-OL COMPOUNDS Pfizer Products Inc. (US) 2007-11-21 EP claimed
WO-2006090250-A1 SUBSTITUTED 1,1,1-TRIFLUORO-3-[(BENZYL)-(PYRIMIDIN-2-YL)-AMINO]-PROP AN-2-OL COMPOUNDS PFIZER PRODUCTS INC. (US) 2006-08-31 WO claimed
EP-1465869-A4 MODULATORS OF LXR X CEPTOR THERAPEUTICS INC (US) 2005-12-28 EP claimed
JP-2005536450-A 2005-12-02 JP claimed
EP-1465869-A1 MODULATORS OF LXR X-Ceptor Therapeutics, Inc. (US) 2004-10-13 EP claimed
US-20030181420-A1 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS, INC. 2003-09-25 US claimed
WO-2003059884-A1 MODULATORS OF LXR X-CEPTOR THERAPEUTICS, INC. (US) 2003-07-24 WO claimed
EP-1192178-A2 RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) ELI LILLY AND COMPANY (US) 2002-04-03 EP claimed
WO-2000078795-A2 RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) ELI LILLY AND COMPANY (US) 2000-12-28 WO claimed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
WO-2023190836-A1 ADDITIVE FOR RESIN, METHOD FOR PRODUCING SAME, AND METHOD FOR SUPPRESSING COLORATION OF RESIN ミヨシ油脂株式会社 2023-10-05 WO disclosed
US-11739171-B2 Method for producing α-olefin/(meth)acrylic acid ester copolymer JAPAN POLYETHYLENE CORPORATION (JP) 2023-08-29 US disclosed
CN-111971310-B Process for producing alpha-olefin/(meth) acrylate copolymer 日本聚乙烯株式会社 2023-07-18 CN disclosed
US-5192783-A Fungicides for plants ROHM AND HAAS COMPANY (US) 1993-03-09 US disclosed
EP-0344110-B1 SUBSTITUTED NAPHTHACENES-5,12-DIONES AND THEIR USE CIBA-GEIGY AG (CH) 1992-09-16 EP disclosed
US-5001243-A Substituted naphthacene-5, 12-diones CIBA-GEIGY CORPORATION (US) 1991-03-19 US disclosed
EP-0344110-A2 Substituted naphthacenes-5,12-diones and their use CIBA-GEIGY AG (CH) 1989-11-29 EP disclosed
CN-86108961-A 1-CARBACEPHALOSPORIN ANTIBIOTICS 1987-08-05 CN disclosed